Yunding Xinyao: The National Medical Products Administration has approved the application for the market of the new drug Weshiping.

Yunding New Announce, the China National Medical Products Administration has approved the application for the marketing of Vistaprin new drug, used in China to treat moderate to severe active ulcerative colitis in adult patients who have responded inadequately or are intolerant to traditional treatment or biologics.